NITROGEN-CONTAINING HETEROCYCLIC AMIDE AND ITS USE FOR MEDICAL PURPOSES Russian patent published in 2023 - IPC C07D487/04 C07D498/04 C07D519/00 A61K31/437 A61K31/4985 A61K31/506 A61P3/10 A61P9/04 A61P9/12 A61P43/00 

Abstract RU 2789670 C2

FIELD: medicine.

SUBSTANCE: invention relates to a compound of the formula [I-a] or the formula [II] or its pharmaceutically acceptable salt, where a dotted line bond is a single bond or a double bond, X1 is a carbon atom, a nitrogen atom, or an oxygen atom, X2 is a carbon atom or a nitrogen atom, R1a is C1-4 alkyl or C1-4 alkyl carbonyl, R2 is halogen, cyano group, or C1-4 alkyl, m is 0 or 1, n is 0, 1, or 2, if n is 2, all R2 are the same or different, A1, A2, A3, A4, A5, A6, and A7 are all independently selected from a group including a carbon atom, a nitrogen atom, and an oxygen atom, A8 is selected from a group including a carbon atom and a nitrogen atom, and the total number of nitrogen atoms and oxygen atoms contained in the structural formula of a fragment (a) is 0, 1, 2, or 3, t is 0 or 1, r is 0, 1, or 2, and the sum of t and r is 1 or 2, w is 0 or 1, R3 and R4, all independently, are hydrogen or C1-4 alkyl; Cy1 is (1) (i) C4-6 cycloalkyl or (ii) 4-6-element saturated or partially saturated heterocyclyl containing one nitrogen atom, C4-6 cycloalkyl and saturated or partially saturated heterocyclyl is optionally substituted with one substitute independently selected from a group including C1-4 alkyl and an oxo group, or (2) (i) phenyl or (ii) 5- or 6-element heteroaryl containing 1, 2, or 3 heteroatoms independently selected from a group including a nitrogen atom and an oxygen atom, phenyl and heteroaryl are optionally substituted with 1 or 2 substitutes independently selected from a group including halogen, cyano group, carboxy group, C1-4 alkyl, halogen-C1-4 alkyl, and C3-6 cycloalkyl; Cy2 is (1) (i) C3-6 cycloalkyl or (ii) 4-6-element saturated heterocyclyl containing 1 or 2 heteroatoms independently selected from a group including a nitrogen atom and an oxygen atom, and C3-6 cycloalkyl and saturated heterocyclyl are optionally substituted with 1 or 2 substitutes independently selected from a group including halogen, hydroxy group, and C1-4 alkyl, or (2) (i) phenyl or (ii) 5- or 6-element heteroaryl containing 1, 2, 3, or 4 nitrogen atoms, and phenyl and heteroaryl are optionally substituted with 1 or 2 substitutes independently selected from a group including halogen, cyano group, C1-4 alkyl, C1-4 alkoxy group, and C1-4 alkyl sulfonyl, and v is 0 or 1. The invention also relates to a pharmaceutical composition having an inhibitory effect on the activity of PDHK1 and 2, containing effective amount of a compound, according to the invention, or its pharmaceutically acceptable salt and a pharmaceutically acceptable carrier. Compounds, according to the invention, are intended for use in the treatment of diseases associated with an inhibitory effect on the activity of PDHK1 and 2.

EFFECT: nitrogen-containing heterocyclic amide, which has an inhibitory effect on pyruvate dehydrogenase kinase (PDHK 1 and 2).

, ,

46 cl, 26 tbl, 140 ex

Similar patents RU2789670C2

Title Year Author Number
DIHYDROPYRIMIDIN-2-ONE COMPOUNDS AND THEIR MEDICAL APPLICATION 2015
  • Ekota Masakhiro
  • Ikenogami Taku
  • Vatanabe Eiiti
  • Seki Noriesi
  • Sakaj Takayuki
  • Fudzioka Singo
  • Siodzaki Makoto
  • Suva Katsunori
  • Ogosi Esuke
  • Noguti Masato
  • Maeda Katsuya
RU2770061C2
PD-L1 ANTAGONIST COMPOUND 2020
  • Yuj, Chzhiyun
  • Li, Pan
  • Syuj, Bejdi
  • Chzhou, Yuj
  • Pan, Vej
  • Ven, Tsyaodun
  • Shi, Yuntsyan
  • Sun, Chzhao
  • Lyuj, Men
RU2823231C1
GCN2 INHIBITORS AND THEIR USE 2019
  • Bayly, Andrew
  • Bleich, Matthew
  • Charrier, Jean-Damien
  • Dodd, James
  • Durrant, Steven
  • Eno, Meredith Suzanne
  • Etxebarria I Jardi, Gorka
  • Everitt, Simon
  • Fraysse, Damien
  • Kelly, Shazia
  • Knegtel, Ronald
  • Mochalkin, Igor
  • Mortimore, Michael
  • North, Kiri
  • Porichis, Filippos
  • Pullin, Robert
  • Rutherford, Alistair
  • Storck, Pierre-Henri
  • Twin, Heather Clare
  • Xiao, Yufang
RU2811408C2
N-ACYLHYDRASONE DERIVATIVES FOR APPLICATION AS SELECTIVE INHIBITORS OF T-CELLS AND MEDICINES FOR LYMPHONEOPLASIA TREATMENT 2013
  • Choj Khochin
  • Li Chevon
  • Li Chkhangon
  • Kha Nina
  • So So Kil
  • Li Sanmi
  • Li Son-Min
RU2622651C2
3-CARBOXY-4-AMINOQUINOLINE DERIVATES, USEFUL AS SWEET TASTE MODIFIERS 2011
  • Tachdzhian Ketrin
  • Tan Sjao-Tsin
  • Karanevski Donald S.
  • Servant Gaj
  • Li Sjaodun
  • Chzhan Fen
  • Chen Tsin
  • Chzhan Khun
  • Devis Timoti
  • Darmokhusodo Vinsent
  • Vong Melissa
  • Selchau Viktor
RU2605549C2
QUINAZOLINE DERIVATIVES 2015
  • Shi Jing
  • Gao Kingzkhi
  • Chen Ksiaozuo
  • Mi Ji
  • Zang Jaran
  • Yang Khanyu
  • Chen Yudzhi
  • Liu Chunlej
  • Mi Guoruj
  • Ma Yuksiu
  • Shen Dongmin
  • Guo Yang
  • Fan Lindzhing
RU2704125C2
ANELLATED 9-HYDROXY-1,8-DIOXO-1,3,4,8-TETRAHYDRO-2H-PYRIDO[1,2-A]PYRAZINE-7-CARBOXAMIDES - INTEGRASE INHIBITORS, METHODS FOR PREPARING AND USING THEREOF 2019
  • Ivashchenko Andrej Aleksandrovich
  • Ivashchenko Aleksandr Vasilevich
  • Mitkin Oleg Dmitrievich
  • Savchuk Nikolaj Filippovich
RU2717101C1
QUINOLINE DERIVATIVES 1995
  • Jutaka Nomura
  • Sogo Sakuma
  • Seiitiro Masui
RU2137770C1
THIOPHENE DERIVATIVE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF 1997
  • Kimura Takenori
  • Murakami Takesi
  • Okhmori Dzunija
  • Morita Takuma
  • Tsukamoto Sin-Iti
RU2172737C2
ANTI-INFECTIOUS COMPOUNDS 2014
  • Kim Dzaeseung
  • Kang Sunkhee
  • Seo Min Dzung
  • Seo Moojoung
  • Seo Dzeongdzea
  • Li Sumi
  • Kang Dzukhee
  • Park Dongsik
  • Kim Riang Jeo
  • Petkhe Kevin
  • Nam Kijean
  • Kim Dzeongdzun
  • Okh Sookhiun
  • Li Saeieon
  • An Dzije
RU2734760C2

RU 2 789 670 C2

Authors

Maeba, Takaki

Sudzava, Koiti

Kotoku, Masayuki

Masuo, Ritsuki

Motoda, Dai

Yamaoka, Nobutaka

Dates

2023-02-07Published

2019-01-30Filed